{"pageContent": "Purpose: We analyzed the outcome of primary androgen depletion therapy, which has gained more attention as a potential therapeutic option in patients with localized or locally advanced prostate cancer as it has been increasingly implemented despite limited data on its therapeutic impact in Japan and the United States.", "metaData": {"source": "Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade\nhttps://pubmed.ncbi.nlm.nih.gov/28560840/"}}